Biomarkers and surrogate endpoints in Duchenne: Meeting report

Neuromuscular Disorders

Volumn 24, Issue 8, 2014, Pages 743-745

  Aartsma Rus, Annemieke ^a   Ferlini, Alessandra ^b   Vroom, Elizabeth ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF FERRARA   (Italy)

^c United Parent Project Muscular Dystrophy   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; DYSTROPHIN; GELATINASE B; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 4; OSTEOPONTIN; UNCLASSIFIED DRUG; LTBP4 PROTEIN, HUMAN; SPP1 PROTEIN, HUMAN;

ARTICLE; BECKER MUSCULAR DYSTROPHY; CK GENE; CONFERENCE PAPER; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DMD GENE; DUCHENNE MUSCULAR DYSTROPHY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE TARGETING; GENETIC CORRELATION; GENETIC MARKER; HETEROZYGOSITY; HUMAN; LTBP4 GENE; MEDICAL RESEARCH; MUSCLE INJURY; NOMENCLATURE; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; SINGLE NUCLEOTIDE POLYMORPHISM; SPP1 GENE; TISSUE DISTRIBUTION; BLOOD; CLINICAL TRIAL (TOPIC); GENETICS; METABOLISM; MUSCULAR DYSTROPHY, DUCHENNE; PATIENT EDUCATION;

BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; CREATINE KINASE; HUMANS; LATENT TGF-BETA BINDING PROTEINS; MUSCULAR DYSTROPHY, DUCHENNE; OSTEOPONTIN; PATIENT EDUCATION AS TOPIC; PROGNOSIS;

EID: 84903944619     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2014.03.006     Document Type: Article

References (0)